Attenuated drinking response induced by angiotensinergic activation of subfornical organ projections to the paraventricular nucleus in estrogen-treated rats.
The present study was carried out to examine whether estrogen modulates the drinking response caused by activation of neural pathways from the subfornical organ (SFO) to the hypothalamic paraventricular nucleus (PVN) in the female rat. Microinjection of angiotensin II (ANG II) into the SFO elicited drinking in ovariectomized female rats that were treated with either propylene glycol (PG) vehicle or estradiol benzoate (EB). The amount of water intake induced by the ANG II injection was significantly greater in the PG-treated than in the EB-treated animals. In both groups, previous injections of either saralasin, an ANG II antagonist, or phentolamine, an alpha-adrenoceptor antagonist, bilaterally into the PVN resulted in the significant attenuation of the drinking response to ANG II, whereas similar injections of saline vehicle into the PVN were without effect. These results suggest that the circulating estrogen may act to reduce the drinking response that is mediated through angiotensinergic and alpha-adrenergic mechanisms in the PVN in response to angiotensinergic activation of SFO efferent projections.
Tanaka
Junichi
J
Department of Curriculum, Teaching and Memory, Neuroscience Program, Naruto University of Education, Naruto, Tokushima 772-8502, Japan. tanakaj@naruto-u.ac.jp
Kariya
Katsuhide
K
Miyakubo
Hiroko
H
Sakamaki
Kazuhiro
K
Nomura
Masahiko
M
D000809:Angiotensins / Q000378:metabolism* / Q000494:pharmacology; D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology; D004326:Drinking / Q000187:drug effects / Q000502:physiology*; D004347:Drug Interactions / Q000502:physiology; D004967:Estrogens / Q000378:metabolism* / Q000494:pharmacology; D004971:Estrus / Q000502:physiology; D005260:Female; D009433:Neural Inhibition / Q000187:drug effects / Q000502:physiology; D009434:Neural Pathways / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D009474:Neurons / Q000187:drug effects / Q000378:metabolism*; D010052:Ovariectomy; D010286:Paraventricular Hypothalamic Nucleus / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D010646:Phentolamine / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D011930:Reaction Time / Q000187:drug effects / Q000502:physiology; D012504:Saralasin / Q000494:pharmacology; D012965:Sodium Chloride / Q000494:pharmacology; D013356:Subfornical Organ / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*
D000809:Angiotensins; D000959:Antihypertensive Agents; D004967:Estrogens; D012965:Sodium Chloride; D012504:Saralasin; D010646:Phentolamine